YF-VAX 1 dose vials
Ended Awarded
- Contract number
- SPE2DR26FCFK0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,838
Award facts
- Contract value 100% obligated
- $27,838.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $27,838 to DMS Pharmaceutical Group Inc. on November 7, 2025, for YF-VAX (yellow fever vaccine) vials to be delivered to Park Ridge, Illinois by December 2, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a routine pharmaceutical procurement under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, that serves as a critical supplier within the federal pharmaceutical supply chain, particularly for Department of Defense medical facilities.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion government-wide acquisition strategy established to provide pharmaceutical and medical consumables to military healthcare facilities worldwide. The underlying IDC, awarded on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, with a 30-month base period followed by three optional 30-month periods. Through this vehicle, DMS Pharmaceutical Group is positioned to deliver a comprehensive range of pharmaceutical products including branded and generic medications, biologics, vaccines, and medical consumables to support the recurring medical supply needs of the Department of Defense healthcare system globally.
Quick answers
Who was awarded contract SPE2DR26FCFK0?
SPE2DR26FCFK0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 7, 2025.
How much is contract SPE2DR26FCFK0 worth?
The government has obligated $27,838 on SPE2DR26FCFK0.
Is contract SPE2DR26FCFK0 an order under another contract?
Yes. SPE2DR26FCFK0 is a delivery order under SPE2DR25D9133, an indefinite delivery contract.
Was contract SPE2DR26FCFK0 competed?
The extent of competition for SPE2DR26FCFK0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award